Document is current

Any future updates will be listed below

Loureirin B inhibits Cervical Cancer Development by Blocking PI3K/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation

Crossref DOI link: https://doi.org/10.1007/s12010-024-04975-7

Published Online: 2024-06-18

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark